A carregar...
Methotrexate and doxycycline interaction: a rare cause of pancytopenia
Methotrexate (MTX) was originally formulated as one of the first antitumour drugs due to its ability to alter folate metabolism, which renders it to be an antiproliferative agent. Classically, the higher dosage is administered via parenteral route, in a cyclical fashion, to achieve antitumour effect...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6557379/ https://ncbi.nlm.nih.gov/pubmed/31154348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229296 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|